1.Hedin, A, Hahn, RG. Volume expansion and plasma protein clearance during intravenous infusion of 5% albumin and autologous plasma. Clin Sci 2005; 106: 217–24.
2.Caironi, P, Tognoni, G, Masson, S, et al. Albumin replacement in patients with severe sepsis or septic shock. N J Engl Med 2014; 370: 1412–21.
3.Fleck, A, Raines, G, Hawker, F, et al. Increased vascular permeability: a major cause of hypoalbuminaemia in disease and injury. Lancet 1985; 325: 781–4.
4.Woodcock, TE, Woodcock, TM. Revised Starling equation and the glycocalyx model of transvascular fluid exchange: an improved paradigm for prescribing intravenous fluid therapy. Br J Anaesth 2012; 108: 384–94.
5.The SAFE Study Investigators. A comparison of albumin and saline for fluid resuscitation in the intensive care unit. N Engl J Med 2004; 350: 2247–56.
6.Guthrie, RD, Hines, C. Use of intravenous albumin in the critically ill patient. Am J Gastroenterol 1991; 86: 255–63.
7.Marik, PE. The treatment of hypoalbuminemia in the critically ill patient. Heart Lung 1993; 22: 166–70.
8.Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: systematic review of randomised trials. BMJ 1998; 317: 235–40.
9.Roberts, I, Edwards, P, McLelland, B. More on albumin. Use of human albumin in UK fell substantially when systematic review was published (letter). BMJ 1999; 318: 1214–15.
10.Wilkes, MM, Navickis, RJ. Patient survival after human albumin administration. A meta-analysis of randomized, controlled trials. Ann Intern Med 2001; 135: 149–64.
11.The SAFE Study Investigators. Saline or albumin for fluid resuscitation in patients with traumatic brain injury. N Engl J Med 2007; 357: 874–84.
12.Rehm, M, Haller, M, Orth, V, et al. Changes in blood volume and hematocrit during acute perioperative volume loading with 5% albumin or 6% hetastarch solutions in patients before radical hysterectomy. Anesthesiology 2001; 95: 849–56.
13.Jacob, M, Chappell, D, Rehm, M. Clinical update: perioperative fluid management. Lancet 2007; 369: 1984–6.
14.Christensen, P, Andersson, J, Rasmussen, SE, Andersen, PK, Henneberg, SW. Changes in circulating blood volume after infusion of hydroxyethyl starch 6% in critically ill patients. Acta Anaesthesiol Scand 2001; 45: 414–20.
15.Lehmann, GB, Asskali, F, Boll, M, et al. HES 130/0.42 shows less alteration of pharmacokinetics than HES 200/0.5 when dosed repeatedly. Br J Anaesth 2007; 98: 635–44.
16.Voluven 6% hydroxyethyl starch 130/0.4 product monograph. Bad Homburg (Germany): Fresenius Kabi, 2007.
17.Hahn, RG, Bergek, C, Gebäck, T, Zdolsek, J. Interactions between the volume effects of hydroxyethyl starch 130/0.4 and Ringer's acetate. Crit Care 2013; 17: R104.
18.Awad, S, Dharmavaram, S, Wearn, CS, Dube, MG, Lobo, DN. Effects of an intraoperative infusion of 4% succinylated gelatine (Gelofusine®) and 6% hydroxyethyl starch (Voluven®) on blood volume. Br J Anaesth 2012; 109: 168–76.
19.Zdolsek, HJ, Vegfors, M, Lindahl, TL, et al. Hydroxyethyl starches and dextran during hip replacement surgery: effects on blood volume and coagulation. Acta Anaesthesiol Scand 2011; 55: 677–85.
20.Li, Y, He, R, Ying, X, Hahn, RG. Dehydration, haemodynamics and fluid volume optimization after induction of general anaesthesia. Clinics 2014; 69: 809–16.
21.James, MF, Latoo, MY, Mythen, MG, et al. Plasma volume changes associated with two hydroxy ethyl starch colloids following acute hypovolaemia in volunteers. Anaesthesia 2004; 59: 738–42.
22.Ickx, BE, Bepperling, F, Melot, C, Schulman, C, van der Linden, PJ. Plasma substitution effects of a new hydroxyethyl starch HES 130/0.4 compared with HES 200/0.5 during and after extended acute normovolaemic haemodilution. Br J Anaesth 2003; 91: 196–202.
23.Schortgen, F, Lacherade, LC, Bruneel, F, et al. Effects of hydroxyethyl starch and gelatine on renal function in severe sepsis: a multicentre randomised study. Lancet 2001; 357: 911–16.
24.Brunkhorst, FM, Engel, C, Bloos, F, et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008; 358: 125–38.
25.Béchir, M, Puhan, MA, Neff, SB, et al. Early fluid resuscitation with hyperoncotic hydroxyethyl starch 200/0.5 (10%) in severe burn injury. Crit Care 2010; 14: R123.
26.Perner, A, Haase, N, Guttormsen, AB, et al. Hydroxyethyl starch 130/0.42 versus Ringer's acetate in severe sepsis. N Engl J Med 2012; 367: 124–34.
27.Myburgh, JA, Finfer, S, Bellomo, R, et al. Hydroxyethyl starch or saline for fluid on intraoperative oliguria resuscitation in intensive care. N Engl J Med 2012; 367: 1901–11.
28.European Medicines Agency. Hydroxyethyl starch for infusion. http://www.ema.europa.eu/ Published on the Internet 06/03/2014.
29.Martin, C, Jacob, M, Vicaut, E, et al. Effect of waxy maize-derived hydroxyethyl starch 130/0.4 on renal function in surgical patients. Anesthesiology 2013; 118: 387–94.
30.van der Linden, P, James, M, Mythen, M, Weiskopf, RB. Safety of modern starches used during surgery. Anesth Analg 2013; 116: 35–48.
31.Gilles, MA, Habicher, M, Jhanji, S, et al. Incidence of postoperative death and acute kidney injury associated with i.v. 6% hydroxyethyl starch use: systematic review and meta-analysis. Br J Anaesth 2014; 112: 25–34.
32.Annane, D, Siami, S, Jaber, S, et al. Effects of fluid resuscitation with colloids vs. crystalloids on mortality in critically ill patients presenting with hypovolemic shock: the CRISTAL randomized trial. JAMA 2013; 310: 1809–17.
33.Laxenaire, MC, Charpentier, C, Feldman, L. Anaphylactoid reactions to colloid plasma substitutes: incidence risk factor mechanisms. A French multicenter prospective study. Ann Fr Anesth Reanimat 1994; 13: 301–10.
34.Hahn, RG. Dextran70 and the blood loss during transurethral resection of the prostate. Acta Anaesthesiol Scand 1996; 40: 820–4.
35.Bulger, EM, May, S, Kerby, J, et al. Out-of-hospital hypertonic resuscitation following traumatic hypovolemic shock: a randomized, placebo controlled trial. Ann Surg 2011; 253: 431–41.
36.Bulger, EM, May, S, Brasel, KJ, et al. Out-of-hospital hypertonic resuscitation following severe traumatic brain injury: a randomized controlled trial. JAMA 2010; 304: 1455–64.
37.Drobin, D, Hahn, RG. Kinetics of isotonic and hypertonic plasma volume expanders. Anesthesiology 2002; 96: 1371–40.
38.Ljungström, K-G. Safety of dextran in relation to other colloids – ten years experience with hapten inhibition. Infusionsther Transfusionsmed 1993; 20: 206–10.
39.Velanovich, V. Crystalloid versus colloid fluid resuscitation: a meta-analysis of mortality. Surgery 1989; 105: 65–71.
40.Schierhout, G, Roberts, I. Fluid resuscitation with colloid or crystalloid solutions in critically ill patients: a systematic review of randomised trials. BMJ 1998; 316: 961–4.
41.Choi, PT, Yip, G, Quinonez, LG, Cook, DJ. Crystalloids vs. colloids in fluid resuscitation: a systematic review. Crit Care Med 1999; 27: 200–10.
42.Li, Y, He, R, Ying, X, Hahn, RG. Ringer's lactate, but not hydroxyethyl starch, prolongs the food intolerance time after major abdominal surgery; an open-labelled clinical trial. BMC Anesthesiol 2015; 15: 72.
43.Varadhan, KK, Lobo, DN. Symposium 3: A meta-analysis of randomised controlled trials of intravenous fluid therapy in major elective open abdominal surgery: getting the balance right. Proc Nutr Soc 2010; 69: 488–98.
44.Brandstrup, B, Tonnesen, H, Beier-Holgersen, R, et al. Effects of intravenous fluid restriction on postoperative complications: comparison of two perioperative fluid regimens. A randomized assessor-blinded multicenter trial. Ann Surg 2003; 238: 641–8.
45.Arieff, AI. Fatal postoperative pulmonary edema. Pathogenesis and literature review. Chest 1999; 115: 1371–7.
46.Hahn, RG. Why crystalloids will do the job in the operating room. Anaesthesiol Intensive Ther 2014; 46: 342–9.
47.Bourke, DL, Smith, TC. Estimating allowable hemodilution. Anesthesiology 1974; 41: 609–12.
48.Ewaldsson, C-A, Hahn, RG. Kinetics and extravascular retention of acetated Ringer's solution during isoflurane and propofol anesthesia for thyroid surgery. Anesthesiology 2005; 103: 460–9.
49.Svensén, C, Hahn, RG. Volume kinetics of Ringer solution, dextran 70 and hypertonic saline in male volunteers. Anesthesiology 1997; 87: 204–12.